Case study: An antibody-drug conjugate targeting MUC16 for ovarian cancer

Leipold, D., & Mallet, W. G. (2013). Case study: An antibody-drug conjugate targeting MUC16 for ovarian cancer. In Antibody-Drug Conjugates and Immunotoxins: From Pre-Clinical Development to Therapeutic Applications (pp. 221–239). Springer New York. https://doi.org/10.1007/978-1-4614-5456-4_13